Advertisement

Progression and Nonprogression of Chronic Renal Failure in Diabetic Nephropathy: Which Factors are Determinants?

  • Gudrun Nyberg
Part of the Topics in Renal Medicine book series (TIRM, volume 6)

Abstract

In the past, the outlook for diabetic patients who developed persistent proteinuria was poor. More than 60% died within 10 years [1], most of them from uremia, because renal replacement therapy (RRT) was not available. The spontaneous rate of progression was shown to vary widely between individuals, but tended to be constant in each subject [2–4]. Jones et al. [3] reported that once serum creatinine had reached 200 μmol/liter the inversed values showed a linear correlation with time. This has been accepted by many authors as a fact valid for the whole range of renal function and during intervention, but it has serious limitations. As stressed by Myer’s group [5], glomerular function should be measured using a true filtration marker. In studies based on such measurements of glomerular filtration rate (GFR), no significant correlation was found between GFR decline and inverse creatinine slope coefficients [4]. An average figure for spontaneous fall rate was about 1 ml/min per month, but the values ranged from 0.13 to 2.47 [3, 4, 6], which is 1.629.6 ml/min per year.

Keywords

Glomerular Filtration Rate Diabetic Nephropathy Protein Intake Continuous Subcutaneous Insulin Infusion Supine Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andersen AR, Sandahl Christiansen J, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983.PubMedCrossRefGoogle Scholar
  2. 2.
    Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 36: 383–388, 1976.PubMedCrossRefGoogle Scholar
  3. 3.
    Jones RH, Hayakawa H, Mackay JD, Parsons V, Watkins PJ: Progression of diabetic nephropathy. Lancet 1: 1105–1106, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Viberti GC, Bilous RW, Mackintosh D, Keen H: Monitoring glomerular function in diabetic nephropathy. Am J Med 74: 256–264, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28: 830–838, 1985.PubMedCrossRefGoogle Scholar
  6. 6.
    Parving HH, Smidt UM, Friiseberg B, Bonnevie-Nielsen V, Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457–461, 1981.PubMedCrossRefGoogle Scholar
  7. 7.
    Viberti GC, Keen H: The patterns of proteinuria in diabetes mellitus: relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes 33: 686–692, 1984.PubMedGoogle Scholar
  8. 8.
    Mogensen CE: Antihypertensive treatment inhibiting the progression of diabetic nephropathy: Acta Endocrinol [Suppl 238] 94: 103–111, 1980.Google Scholar
  9. 9.
    Parving HH, Andersen AR, Smidt UM, Svendsen PAa: Early aggressive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1179, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Mathiesen ER, Oxenböll B, Johansen K, Svendsen PAa, Deckert T: Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H: Glycaemia, arterial pressure and micro-albuminuria, in type I (insulin-dependent) diabetes mellitus. Diabetologia 26: 401–405, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Parving HH, Andersen AR, Hommel E, Smidt U: Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension [Suppl 2] 7:1I-114-II117, 1985.Google Scholar
  13. 13.
    Bending JJ, Viberti GC, Watkins PJ, Keen H: Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J 292: 83–86, 1986.CrossRefGoogle Scholar
  14. 14.
    Nyberg G, Blohmé G, Nordén G: Constant glomerular filtration rate in diabetic nephropathy: correlation to blood pressure and blood glucose control. Acta Med Scand 219: 67–72, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    Weidmann P, Beretta-Piccoli C, Keusch G, Glück Z, Mujagic M, Grimm M, Meier A, Ziegler WH: Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 67: 779–784, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    O’Hare JA, Ferriss JB, Brady D, Twomey B, O’Sullivan DJ: Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension [Suppl 2] 7:11–43–11–48, 1985.Google Scholar
  17. 17.
    Björck S, Delin K, Herlitz H, Larsson O, Aurell M: Renin secretion in advanced diabetic nephropathy. Scand J Urol Nephrol [Suppl] 79: 53–57, 1984.Google Scholar
  18. 18.
    Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380, 1982.PubMedCrossRefGoogle Scholar
  19. 19.
    Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 467–470, 1986.CrossRefGoogle Scholar
  20. 20.
    Parving HH, Andersen A, Smidt U, Hommel E, Mathiesen E: The effect of long-term anti-hypertensive treatment on kidney function in diabetic nephropathy [abstr]. Diabetologia 29: 580A, 1986.Google Scholar
  21. 21.
    Hasslacher C, Stech W, Wahl P, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type I (insulin-dependent) diabetes. Diabetologia 28: 6–11, 1985.PubMedCrossRefGoogle Scholar
  22. 22.
    Stephen RL, Maxwell JG, Harrow JJ, Jacobsen SC, Hanover BK: Intervention in nephropathy due to insulin-dependent diabetes mellitus (IDDM). Kidney Int [Suppl 17] 28:5–60—S65, 1985.Google Scholar
  23. 23.
    Viberti GC, Bilous RW, Machintosh D, Bending JJ, Keen H: Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J 286: 598–602, 1983.CrossRefGoogle Scholar
  24. 24.
    Cataland S, O’Dorisio TM: Diabetic nephropathy: clinical course in patients treated with the subcutaneous insulin pump. JAMA 249: 2059–2061, 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Berglund J, Lins L-E, Lins P-E: Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand 218: 401–408, 1985.PubMedCrossRefGoogle Scholar
  26. 26.
    Nyberg G, Blohmé G, Nordén G: Impact of metabolic control on progression of clinical diabetic nephropathy. Diabetologia 30: 82–86, 1987.PubMedGoogle Scholar
  27. 27.
    Nyberg G, Nordén G, Attman PO, Aurell M, Uddebom G, Arvidsson-Lenner R, Isaksson B: Diabetic nephropathy: is dietary protein harmful? J Diabetic Complications 1: 37–40, 1987.CrossRefGoogle Scholar
  28. 28.
    Viberti GC, Wiseman MJ, Bending JJ: Prevention of diabetic nephropathy: markers of disease and perspectives for intervention. Diabetic Med 3: 208–211, 1986.PubMedCrossRefGoogle Scholar
  29. 29.
    Bending JJ, Dodds R, Keen H, Viberti GC: Lowering protein intake and the progression of diabetic renal failure [abstr]. Diabetologia 29: 516A, 1986.Google Scholar
  30. 30.
    McCulloch DK, Young RJ, Steel JM, Wilson EM, Prescott RJ, Duncan LJP: Effect of dietary compliance on metabolic control in insulin-dependent diabetics. Hum Nutr Appl Nutr 37A: 287–292, 1983.PubMedGoogle Scholar
  31. 31.
    Barnett AH, Pyke DA: The genetics of diabetic complications. Clin Endocrinol Metab 15: 715–726, 1986.PubMedCrossRefGoogle Scholar
  32. 32.
    Nyberg G, Larsson 0, Attman P-0, Granerus G, Nordén G: Time as a risk factor in diabetic nephropathy. Diabetes Care 8: 590–593, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Mühlhauser I, Sawicki P, Berger M: Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type I (insulin-dependent) diabetes. Diabetologia 29: 500–502, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    Frimodt-Möller C: Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med (part 2 ) 92: 318–321, 1980.Google Scholar
  35. 35.
    Ellenberg M: Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med (part 2 ) 92: 321–323, 1980.Google Scholar
  36. 36.
    Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT: The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 21: 730–738, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Gudrun Nyberg

There are no affiliations available

Personalised recommendations